test 02202Y 深 沪
等待开盘 12-20 09:30:00 美东时间
1.00
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 1.00
- 总市值 10000
- 52周最高 1.00
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.00
- 委 比 0.00%
- 总股本 10000
- 历史最高 1.00
- 量 比 0
- 振 幅 0.00%
- 历史最低 1.00
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Altimmune's MASH Drug Shows Durable Liver, Weight Loss Gains At 48 Weeks
Altimmune reports positive 48-week Phase 2b data for pemvidutide in MASH, showing fibrosis improvement, weight loss, and strong tolerability.
今天 01:57
Markets Bounce, CPI Cools, And Nike Earnings Stumble
Stocks rallied yesterday as softer inflation data hit the tape, but Nike's latest report raises fresh questions about global demand.
今天 01:09
Market Whales and Their Recent Bets on UBER Options
Investors with a lot of money to spend have taken a bullish stance on Uber Tech...
今天 00:00
Congressman Can't Stop Buying Magnificent 7 Stocks: These Are His Latest Picks
A member of Congress who has poured millions into six of the seven Magnificent Seven stocks in 2025 appears to favor one above the rest.
12-19 23:48
As Investor Sentiment Shifts Toward High-Tech Offerings, Will Banu's Hong Kong IPO Thrive?
The premium hotpot chain has updated its Hong Kong IPO application, but could f...
12-19 20:26
Top Wall Street Forecasters Revamp Conagra Brands Expectations Ahead Of Q2 Earnings
Conagra Brands, Inc. (NYSE:CAG) will release earnings results for its second qu...
12-19 15:57
Active ETF Wars Heat Up As AllianceBernstein Rolls Out New Tax-Efficient ETF
The AB US Equity ETF (XCHG), an actively managed U.S. equity ETF, is focused on long-term growth and tax-efficient portfolio construction.
12-19 06:22
Spotlight on Uber Technologies: Analyzing the Surge in Options Activity
Whales with a lot of money to spend have taken a noticeably bearish stance on U...
12-19 04:01
Sotera Health Trades At Deep Discount Despite Best-In-Class Margins: Analyst
Sotera Health, a sterilization solutions provider, is gaining investor attention due to easing litigation and improving cash flow.
12-19 03:30
Takeda's Once-Daily Psoriasis Pill Hits Phase 3 Goals, Beats Amgen's Drug
Takeda reports positive Phase 3 data for psoriasis drug zasocitinib, beating placebo and Otezla, with rapid PASI responses and FDA filing plans.
12-19 03:10
